Sclerotic-type chronic graft-versus-host disease exhibits activation of Th1 and OX40 cytokines.

Kim M, Renert-Yuval Y, Stepensky P, Even-Or E, Zaidman I, Fachler T, Neumark M, Zamir M, NandyMazumdar M, Gour D, et al. Sclerotic-type chronic graft-versus-host disease exhibits activation of Th1 and OX40 cytokines. J Invest Dermatol. 2023.